Skip to main content

Table 5 Epidemiological information on Group 1

From: Effects of rhBMP-2 with various carriers on maxillofacial bone regeneration through computed tomography evaluation

 

Group 1

Group 1–1 (n = 34)

Group 1–2 (n = 5)

Group 1–3 (n = 14)

Age (years)

44.86 ± 14.97

51.80 ± 9.73

48.71 ± 18.47

Gender

 Male

19

3

6

 Female

15

2

8

Diagnosis

 Cyst

5

1

1

 Benign tumor

27

2

7

 Osteomyelitis

0

0

6

 Inflammation

2

2

0

 Defect size (cc)

3.569 ± 1.825

3.073 ± 0.981

5.162 ± 3.177

 Compromised wall

1.07

1.2

1.79